Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03620474
Recruitment Status : Active, not recruiting
First Posted : August 8, 2018
Last Update Posted : April 6, 2021
Sponsor:
Collaborators:
PRISM BioLab Co.,Ltd.
Kyushu University
National Center for Global Health and Medicine, Japan
Japan Agency for Medical Research and Development
Ohara Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Kiminori Kimura, MD, Komagome Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2022
Estimated Study Completion Date : March 2022